CN102824471B - Traditional Chinese medicine drug for treating spinal disc herniation, sciatica and leg pain - Google Patents
Traditional Chinese medicine drug for treating spinal disc herniation, sciatica and leg pain Download PDFInfo
- Publication number
- CN102824471B CN102824471B CN201210306134.7A CN201210306134A CN102824471B CN 102824471 B CN102824471 B CN 102824471B CN 201210306134 A CN201210306134 A CN 201210306134A CN 102824471 B CN102824471 B CN 102824471B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- sciatica
- root
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses traditional Chinese medicine drug for treating spinal disc herniation, sciatica and leg pain. The traditional Chinese medicine drug for treating spinal disc herniation, sciatica and leg pain comprises, by weight, 5-10 parts of bark of eucommia, 10-20 parts of root of red-rooted salvia, 5-18 parts of seahorse, 15-35 parts of medicinal cyathula root, 15-35 parts of cassia twig, 10-25 parts of herba Cistanche, 15-20 parts of wolfberry fruit, 10-20 parts of root of Angelica pubescens, 2-6 parts of pseudo-ginseng, 2-8 parts of safflower, 2-10 parts of herba epimedii, 2-10 parts of rhizome of davallia, 10-20 parts of notopterygium root, 1-5 parts of root of Iris decora Wall, and 4-8 parts of nandina root. The nandina root used in the drug has the effects of dispelling the wind, clearing heat, clearing damp and resolving phlegm and is well effective in treating spinal disc herniation, sciatica and leg pain. Clinical applications and observations show that the traditional Chinese medicine drug has the advantages of recurrence of spinal disc herniation, sciatica and leg pain is less easy, and the drug has low side effects.
Description
technical field:
The present invention relates generally to the field of Chinese medicines, relates in particular to a kind of Chinese medicine for the treatment of prolapse of lumbar intervertebral disc, sciatica and skelalgia.
background technology:
Because people's rhythm of life is fast, in operating pressure, in crowd, the sickness rate of the diseases such as prolapse of lumbar intervertebral disc, sciatica, skelalgia is in rising trend, become a kind of commonly encountered diseases and frequently-occurring disease, and present that medical expense is high, relapse rate is high and cause injury the high defect that disables.At present, be symptomatic drugs treatment clinically mostly, can only alleviate pain for the moment.And adopt operation or physical therapy, there is the defect that expense is high, side effect is large.
summary of the invention:
The object of the invention is exactly in order to make up the defect of prior art, and a kind of Chinese medicine that utilizes treatment prolapse of lumbar intervertebral disc, sciatica and skelalgia is provided, and has the advantage of good effect, instant effect, difficult recurrence.
The present invention is achieved by the following technical solutions:
The Chinese medicine for the treatment of prolapse of lumbar intervertebral disc, sciatica and skelalgia, is characterized in that: the weight proportion of its each raw material components is: Cortex Eucommiae 5-10, Radix Salviae Miltiorrhizae 10-20, Hippocampus 5-18, Radix Cyathulae 15-35, Ramulus Cinnamomi 15-35, Herba Cistanches 10-25, Fructus Lycii 15-20, Radix Angelicae Pubescentis 10-20, Radix Notoginseng 2-6, Flos Carthami 2-8, Herba Epimedii 2-10, Rhizoma Drynariae 2-10, Rhizoma Et Radix Notopterygii 10-20, little flat careless 1-5, Radix Nandinae Domesticae 4-8.
The Chinese medicine for the treatment of prolapse of lumbar intervertebral disc, sciatica and skelalgia, is characterized in that: the weight proportion of its each raw material components is: the Cortex Eucommiae 8, Radix Salviae Miltiorrhizae 15, Hippocampus 10, Radix Cyathulae 20, Ramulus Cinnamomi 20, Herba Cistanches 18, Fructus Lycii 17, Radix Angelicae Pubescentis 15, Radix Notoginseng 4, Flos Carthami 5, Herba Epimedii 6, Rhizoma Drynariae 6, Rhizoma Et Radix Notopterygii 15, little flat careless 3, Radix Nandinae Domesticae 6.
Advantage of the present invention is:
The present invention has good curative effect for treatment prolapse of lumbar intervertebral disc, sciatica and skelalgia, and by clinical practice and observation, the present invention has the recurrence of being difficult for, the advantage that side effect is little.
the specific embodiment:
The Chinese medicine for the treatment of prolapse of lumbar intervertebral disc, sciatica and skelalgia, the weight of its each raw material components (g) is: the Cortex Eucommiae 8, Radix Salviae Miltiorrhizae 15, Hippocampus 10, Radix Cyathulae 20, Ramulus Cinnamomi 20, Herba Cistanches 18, Fructus Lycii 17, Radix Angelicae Pubescentis 15, Radix Notoginseng 4, Flos Carthami 5, Herba Epimedii 6, Rhizoma Drynariae 6, Rhizoma Et Radix Notopterygii 15, little flat careless 3, Radix Nandinae Domesticae 6.
The raw material components that takes above corresponding group, according to the routine fashion of decoction, adds water and boil decoction and takes, every day potion, potion divides to be taken for three times.
For checking therapeutic effect of the present invention, spy carries out following experimental technique, and test method adopts random packet, control experiment method.
Choose 40 routine prolapse of lumbar intervertebral disc patients, adopt random digit table method to be divided at random two groups this 40 routine patient.Male's 14 examples in matched group 20 examples, women's 6 examples, age 30-68 year, 50 years old mean age.In treatment group 20 examples, male's 12 examples, women's 8 examples, age 28-65 year, 48 years old mean age.
Treatment standard is the criterion of therapeutical effect of prolapse of lumbar intervertebral disc in < < disease of tcm Standardization of diagnosis and curative effect > >:
Recovery from illness: more than lumbago and skelalgia disappears, directly lower limb is raised 70cm, each pressure pain point disappears, and can resume work.
Take a turn for the better: lumbago and skelalgia alleviates, waist movable function improves.
Invalid: symptom alleviates, functional rehabilitation is not obvious.
For matched group: adopt common Western medicine method treatment.The treatment by Chinese herbs of the present invention that gives for treatment group.
Observe 2 months, therapeutic outcome is as follows:
? | Effective | Effectively | Invalid |
Treatment group number | 14 | 6 | 0 |
Contrast groups number | 5 | 13 | 2 |
Now provide following model case to confirm:
Case one:
Wang, female, 41 years old.Examine in October, 2010.L4/5, L5/S1 central type intervertebral disk hernia, two numbnesss of lower limbs, just there is powerlessness in the 10 minutes two lower limb of standing.Adopt Chinese medicine of the present invention, after 10 days, symptom alleviates, and after 20 days, patient cures.
Case two:
Model, man, 50 years old.Main suit: after wind and cold, under right side, waist and right buttocks are down to more than thigh rear side, shank pain half a year, and the pain increased after recently tired comes institute medical.Check: the right other tenderness of L4~L5 is obvious, and right buttocks and thigh rear side are along there being obvious tenderness on bladder meridian path, and right knee joint, Achilles tendon reflex weaken, and right lower limb straight-leg raising test is positive, and x-ray is taken the photograph sheet and shown normal lumbar vertebra.Be diagnosed as primary sciatica.Adopt treatment by Chinese herbs of the present invention after two weeks, pain relief; After one and a half months, symptom and sign disappear completely, cure.
Claims (2)
1. the Chinese medicine for the treatment of prolapse of lumbar intervertebral disc, sciatica and skelalgia, is characterized in that: the weight proportion of its each raw material components is: Cortex Eucommiae 5-10, Radix Salviae Miltiorrhizae 10-20, Hippocampus 5-18, Radix Cyathulae 15-35, Ramulus Cinnamomi 15-35, Herba Cistanches 10-25, Fructus Lycii 15-20, Radix Angelicae Pubescentis 10-20, Radix Notoginseng 2-6, Flos Carthami 2-8, Herba Epimedii 2-10, Rhizoma Drynariae 2-10, Rhizoma Et Radix Notopterygii 10-20, little flat careless 1-5, Radix Nandinae Domesticae 4-8.
2. the Chinese medicine that utilizes Radix Nandinae Domesticae treatment prolapse of lumbar intervertebral disc, sciatica and skelalgia according to claim 1, is characterized in that: the weight proportion of its each raw material components is: the Cortex Eucommiae 8, Radix Salviae Miltiorrhizae 15, Hippocampus 10, Radix Cyathulae 20, Ramulus Cinnamomi 20, Herba Cistanches 18, Fructus Lycii 17, Radix Angelicae Pubescentis 15, Radix Notoginseng 4, Flos Carthami 5, Herba Epimedii 6, Rhizoma Drynariae 6, Rhizoma Et Radix Notopterygii 15, little flat careless 3, Radix Nandinae Domesticae 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210306134.7A CN102824471B (en) | 2012-08-27 | 2012-08-27 | Traditional Chinese medicine drug for treating spinal disc herniation, sciatica and leg pain |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210306134.7A CN102824471B (en) | 2012-08-27 | 2012-08-27 | Traditional Chinese medicine drug for treating spinal disc herniation, sciatica and leg pain |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102824471A CN102824471A (en) | 2012-12-19 |
CN102824471B true CN102824471B (en) | 2014-03-05 |
Family
ID=47327917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210306134.7A Expired - Fee Related CN102824471B (en) | 2012-08-27 | 2012-08-27 | Traditional Chinese medicine drug for treating spinal disc herniation, sciatica and leg pain |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102824471B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107320683A (en) * | 2017-06-30 | 2017-11-07 | 范闯法 | A kind of Chinese medicine for treating caput femoris necrosis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101450197B (en) * | 2008-12-19 | 2011-03-23 | 杨银香 | Traditional Chinese medicine for treating rheumatism, rheumatoid disease |
CN102293853B (en) * | 2011-08-10 | 2013-08-14 | 内蒙古中安类风湿骨关节病专科医院有限责任公司 | Chinese medicinal pills for treating Bi syndrome |
-
2012
- 2012-08-27 CN CN201210306134.7A patent/CN102824471B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102824471A (en) | 2012-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101972454B (en) | Medicament for treating lymphoma | |
CN100506274C (en) | Traditional Chinese medicine for treating cervical vertebra disease | |
CN104547790A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis and preparation method thereof | |
CN102228603B (en) | Chinese medicine for treating retention of urine | |
CN105832837A (en) | Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion | |
CN103340976A (en) | Drug for treating neck, shoulder, waist and leg pain | |
CN102198243B (en) | Oviduct dredging medicament for removing blood stasis and warming meridians | |
CN104984191A (en) | Traditional Chinese medicine composition for treating acute lumbar muscle sprain | |
CN103446360B (en) | Traditional Chinese medicine capsule preparation for treating lumbar disc herniation and preparation method of traditional Chinese medicine capsule preparation | |
CN101361949A (en) | Traditional Chinese medicine for treating gynaecologic emmeniopathy | |
CN102266489A (en) | Medicament for treating breast cancer | |
CN102824471B (en) | Traditional Chinese medicine drug for treating spinal disc herniation, sciatica and leg pain | |
CN104383479A (en) | Traditional Chinese medicine foot bath composition for treating varicosity and preparation method of traditional Chinese medicine foot bath composition | |
CN105412626A (en) | Medicine preparation for treating cervical spine bone hyperplasia and application of medicine preparation | |
CN105435210A (en) | Traditional Chinese medicine oriented permeable drug treatment liquid for treating cold-dampness stasis type lumbar disc herniation and preparation method thereof | |
CN102349949B (en) | Traditional Chinese medicine ischium pain-relieving decoction for treating sciatica | |
CN103263645B (en) | Gastritis and gastric ulcer treatment drug | |
CN103690621A (en) | Traditional Chinese medicine decoction for treating scapulohumeral periarthritis | |
CN103099879A (en) | Traditional Chinese medicine (TCM) preparation for treating fifth-watch diarrhea | |
CN107715100B (en) | Traditional Chinese medicine compound for treating cold-dampness type lumbar intervertebral disc protrusion of middle-aged and old people and application thereof | |
CN102430066B (en) | Sciatic nerve liquid | |
CN105727245A (en) | Internal traditional Chinese medicine composition for treating cervical and lumbar diseases | |
CN104383211A (en) | Traditional Chinese medicine clysis fluid for treating chronic renal insufficiency and yang deficiency-induced cold of diabetic nephropathy | |
CN102824484B (en) | Plaster for treating lumbar disc herniation | |
CN103830684A (en) | Pharmaceutical composition for curing hypermenorrhea and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140305 Termination date: 20150827 |
|
EXPY | Termination of patent right or utility model |